ILMU KESIHATAN Weblog

ILMU KESIHATAN UNTUK BANGSA MALAYSIA DAN INDONESIA

KAJIAN SAINS

JEUNESSE Inc.

Institute of Longevity Medicine 11/5/99

PRELIMINARY REPORT (additional test results to follow)
Transfer Factor Testing

Background and rationale: Cancer is the second leading cause of death in the US. The rate of nearly every type of cancer is on the rise. Despite billions of dollars in research, the mortality rate has remained virtually unchanged since the 1960’s using conventional treatments such as radiation, surgery, and chemotherapy. Thus, there is considerable interest in using immune modulation as an adjuvant for cancer therapy. Natural killer cells are particularly important in destroying cancer cells.

Purpose of study: To determine the in vitro anti-cancer effects of Transfer FactorÔ and Transfer Factor PlusÔ using PBMC isolated from human volunteers and assaying the increased ability of the NK cell population to kill K562 erythroleukemic cells.

Methods: 1) PBMC killing of K562 (erythroleukemic) cells

Results: 2) Transfer Factor increased NK-cell killing by 103% and Transfer Factor PlusÔ by 248%

Conclusions: Transfer FactorÔ and Transfer Factor PlusÔ induced immune-based lysis of K562 cells at a level unprecedented in the director’s experience or in the known medical literature. Since NK cell function is so crucial in killing cancer cells, these products are ideal candidates for cancer adjuvant therapy. In addition, NK cells form a first line of defense against infections from viruses and certain other microorganisms. Killing assays against K562 cells have also been correlated with increased activity against chronic and acute infections as well.

Darryl See, M.D.
Director, Bioassay Laboratory
Institute of Longevity Medicine
Huntington Beach, CA 92648


Transfer Factor Study

(4Life)

N.K. Assay, October 27, 1999

Sample Name

#of Live K562 Cells

#of Dead K562 Cells

Mean of Dead cells

% Increase In Killing

Baseline – a

95.8

42

Baseline – b

96.9

3.1

3.7

Positive (PBMC) – a

95.2

4.8

Positive (PBMC) – b

94.8

5.2

5.0

Negative (Flour) – a

94.2

5.8

Negative (Flour) – b

94.7

5.3

5.6

Transfer Factor – a

87.8

12.2

Transfer Factor – b

89.7

10.3

11.3

103%

Transfer Factor Plus Study (4Life)

N.K. Assay November 4,1999

Sample None

#of Live K562 Cells

#of Dead K562 Cells

Mean of Dead cells

% Increase In Killing

Baseline – a

99

1.3

Baseline – b

98.1

1.9

1.6

Positive (PBMC) – a

95.8

42

Positive (PBMC) – b

97.1

2.9

3.6

Negative (Flour) – a

97.3

2.7

Negative (Flow) – b

96.6

3.4

3.1

Transfer Factor Plus(200 m l) – a

89.7

10.3

Transfer Factor Plus(200 m l) – b

69.1

10.9

10.6

248%

Transfer Factor Plus(20 m l) – a

91.8

8.2

Transfer Factor Plus(20 m l ) – b

92.3

7.7

8.0

161%

Transfer Factor and Transfer Factor Plus Study (4Life)

Toxicity Assay November 9, 1999

Sample

Result

Transfer Factor (2 mg)

No toxicity observed

Transfer Factor (200 m g)

No toxicity observed

Transfer Factor Plus (2 mg)

No toxicity observed

Transfer Factor Plus (200 m g)

No toxicity observed

Nutraceutical Induced Increase in
Natural Killer Cell (NK) Activity

Purpose of Study: To determine the in vitro Natural Killer Cell (NK) activation effects of 4 Life Transfer Factor and Transfer Factor Plus using peripheral blood mononuclear cells (PBMC) isolated from human volunteers and assaying the increased ability of the NK cell population to kill K562 erthroleukemic cells.

Conclusions: 4Life Transfer Factor and Transfer Factor Plus induced immune-based lysis (breakdown) of K562 cells at a level unprecedented in the director’s experience or in any known medical literature, Since NK cell function is so crucial in killing dangerous Cells, these products are ideal candidates for human and animal immune support.

Nutraceutical Tested

Percent (%) Rise in

NK Cell Activity

4Life Transfer Factor Plus

248%

4Life Transfer Factor

103%

IP6 (highest of group Previously tested)

49%

Plant Polysaccharide Formula

48%

Echinacea

47%

Shitake Mushroom

42%

Cordecep Formula

28%

Bovine Colostrum

23%

Phytonutrient Formula with Garlic

21%

Endocrine System Formula

16%

Concentrate (acemannan)

15%

Noni (Morinda citrafolia)

15%

Some of these products reflect an average of different brands.

Baseline activity is the measure of the unassisted ability of white blood cells to kill K562 leukemia (cancer) cells.

Natural Killer Cells are the body’s first line of defense against cancers and viruses.

The increase in the ability of white blood cells to kill K562 cancer cells is directly related to the increase in Natural Killer Cell activity.

This study does not claim nor should it be interpreted to cure, prevent or mitigate any serious disease. The results have been reported as they were received. Seek advise from your health professional before beginning any new regimen

January 27, 2008 - Posted by | 4LIFE, BARAH, kanser | , , , , , , , ,

No comments yet.

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: